Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CAS Announces Stem Cell Initiative

publication date: Feb 11, 2011
The Chinese Academy of Sciences (CAS) wants to make a name for China science by moving into the front rank of stem cell research. To accomplish this, the CAS has set up a formal research platform and base for stem cell and regenerative medicine research with Qi Zhou, PhD, Institute of Zoology, CAS, as chief scientist. The platform named four core research centers in Beijing, Shanghai, Guangzhou and Kunming as the base of the platform, and it will complete the platform by adding the resources of 17 additional research institutions around the country. More details....


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital